Viewing Study NCT00840333


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2025-12-26 @ 7:05 PM
Study NCT ID: NCT00840333
Status: COMPLETED
Last Update Posted: 2024-12-04
First Post: 2009-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module